NAA50
N-alpha-acetyltransferase 50
Also known as: FLJ13194, MAK3, NAA50_HUMAN, NAT13, NAT5, San
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9GZZ1
- Gene
- NAA50
- Ensembl
- ENSG00000121579
- Chromosome
- 3
- Canonical length
- 169 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoli
OverviewNCBI Gene
Enables histone H4 acetyltransferase activity and protein-N-terminal amino-acid acetyltransferase activity. Involved in N-terminal protein amino acid acetylation; establishment of mitotic sister chromatid cohesion; and mitotic sister chromatid cohesion, centromeric. Located in cytosol and nucleolus. Part of NatA complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
169 residues, UniProt reviewed canonical sequence.
>Q9GZZ1|NAA50
1 MKGSRIELGD VTPHNIKQLK RLNQVIFPVS YNDKFYKDVL EVGELAKLAY FNDIAVGAVC
61 CRVDHSQNQK RLYIMTLGCL APYRRLGIGT KMLNHVLNIC EKDGTFDNIY LHVQISNESA
121 IDFYRKFGFE IIETKKNYYK RIEPADAHVL QKNLKVPSGQ NADVQKTDNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAA50 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 259 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 259 nTPM
- tongue: 114 nTPM
- esophagus: 71 nTPM
- bone marrow: 66 nTPM
- tonsil: 65 nTPM
- adipose tissue: 65 nTPM
Single-cell type
- myonuclei: 355 nCPM
- esophageal apical cells: 295 nCPM
- basal keratinocytes: 212 nCPM
- suprabasal keratinocytes: 208 nCPM
- erythrocyte progenitors: 193 nCPM
- neutrophils: 191 nCPM
Immune cell
- memory B-cell: 52 nTPM
- total PBMC: 50 nTPM
- neutrophil: 48 nTPM
- gdT-cell: 43 nTPM
- myeloid DC: 42 nTPM
- classical monocyte: 39 nTPM
Brain region
- cerebral cortex: 70 nTPM
- white matter: 69 nTPM
- thalamus: 68 nTPM
- choroid plexus: 67 nTPM
- pons: 65 nTPM
- spinal cord: 63 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.73
- gnomAD missense Z
- 1.78
- DepMap mean gene effect
- -1.69
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- establishment of mitotic sister chromatid cohesion
- mitotic sister chromatid cohesion
- mitotic sister chromatid cohesion, centromeric
- N-terminal protein amino acid acetylation
- post-translational protein modification
Molecular functions
- histone H4 acetyltransferase activity
- protein N-terminal-methionine acetyltransferase activity
- protein-lysine-acetyltransferase activity
- protein-N-terminal amino-acid acetyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GNAT domain
- Acyl-CoA N-acyltransferase
- Acetyltransferase (GNAT) family
- N-terminal and lysine N-acetyltransferase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAA50 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAA50 as an antibody target. Whether an autoantibody or antibody against NAA50 could matter depends on whether native NAA50 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAA50 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAA50 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...